Hwa Yeon Ko

Risk of hepatic events associated with use of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists, and thiazolidinediones among patients with metabolic dysfunction-associated steatotic liver disease

Sungho Bea, Hwa Yeon Ko, Jae Hyun Bae et al. · Gut · 2024 · 48 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Sodium–Glucose Cotransporter-2 Inhibitors, Dulaglutide, and Risk for Dementia

Bin Na Hong, Sungho Bea, Hwa Yeon Ko et al. · Annals of Internal Medicine · 2024 · 30 citations

Medicine, Pharmacology, Pharmacotherapy +17

Sodium-Glucose Cotransporter 2 Inhibitors vs Incretin-Based Drugs and Risk of Fractures for Type 2 Diabetes

Hwa Yeon Ko, Sungho Bea, Han Eol Jeong et al. · JAMA Network Open · 2023 · 20 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Barriers to COVID-19 vaccine surveillance: the issue of under-reporting adverse events

Yunha Noh, Hwa Yeon Ko, Ju Hwan Kim et al. · Epidemiology and Health · 2023 · 12 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Treatment Patterns and Persistence Among Patients Newly Diagnosed With Migraine in South Korea: A Retrospective Analysis of Health Claims Data

Ki Yeon Kim, Hwa Yeon Ko, Sungho Bea et al. · Journal of Clinical Neurology · 2024 · 10 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15